当前位置:首页 - 行情中心 - 佐力药业(300181) - 财务分析

佐力药业

(300181)

  

流通市值:111.66亿  总市值:129.90亿
流通股本:6.03亿   总股本:7.01亿

佐力药业(300181)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润3.79亿元,每股收益0.53元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益310686.24万元,未分配利润80429.70万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产459939.56万元,负债149253.32万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,599,453,446.18824,425,237.082,577,878,166.872,044,879,347.76
营业总成本1,184,629,333.23623,213,469.792,050,169,103.691,611,761,923.04
其他经营收益
营业利润451,582,737.74215,782,928.9609,287,521.8503,943,533.36
利润总额447,894,777.16213,737,051.88596,692,741.94494,787,012
净利润379,193,091.62183,386,181.52515,958,086.72427,382,283.28
每股收益
其他综合收益266,901,782.73122,157,526.1856,170,995.22-33,438,805.14
综合收益总额646,094,874.35305,543,707.7572,129,081.94393,943,478.14
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,298,188,032.452,436,673,465.922,177,445,545.682,268,385,541.17
非流动资产:
非流动资产合计2,301,207,601.312,132,597,487.631,814,510,308.721,604,053,486.82
资产总计4,599,395,633.764,569,270,953.553,991,955,854.43,872,439,027.99
流动负债:
流动负债合计1,265,310,381.531,211,726,378.451,056,049,174.341,174,080,546.09
非流动负债:
非流动负债合计227,222,846.97176,247,420.58116,465,923.9457,103,329.58
负债合计1,492,533,228.51,387,973,799.031,172,515,098.281,231,183,875.67
所有者权益(或股东权益):
归属于母公司股东权益合计3,038,206,441.683,119,349,403.152,768,884,681.972,599,700,232.89
股东权益合计3,106,862,405.263,181,297,154.522,819,440,756.122,641,255,152.32
负债和股东权益合计4,599,395,633.764,569,270,953.553,991,955,854.43,872,439,027.99
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,549,438,051.75543,904,627.722,737,184,821.021,914,094,723.01
经营活动现金流出小计1,259,854,039.72621,343,007.732,440,137,580.621,699,968,873.74
经营活动产生的现金流量净额289,584,012.03-77,438,380.01297,047,240.4214,125,849.27
投资活动产生的现金流量:
投资活动现金流入小计6,016,998-152,637,738.72152,158,992.83
投资活动现金流出小计172,353,433.32129,980,161.09262,888,474155,734,614.68
投资活动产生的现金流量净额-166,336,435.32-129,980,161.09-110,250,735.28-3,575,621.85
筹资活动产生的现金流量:
筹资活动现金流入小计540,300,750231,900,750531,376,625377,680,678
筹资活动现金流出小计716,195,863.8791,817,446.55870,762,632.22733,526,863.59
筹资活动产生的现金流量净额-175,895,113.87140,083,303.45-339,386,007.22-355,846,185.59
汇率变动对现金及现金等价物的影响-103.54-25.55162.35-31.53
现金及现金等价物净增加额-52,647,640.7-67,335,263.2-152,589,339.75-145,295,989.7
期末现金及现金等价物余额722,907,412.44735,440,496.99775,555,053.14783,196,028.54
补充资料:
现金及现金等价物的净增加额-52,647,640.7--152,589,339.75-
最新报告期:2025-08-22
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券宋硕,陈竹0.921.091.292025-08-22
华西证券崔文亮0.951.201.502025-08-22
长城证券刘鹏,袁紫馨0.951.141.382025-08-21
长江证券张楠,彭英骐0.941.211.552025-08-21
开源证券余汝意,巢舒然0.951.201.522025-08-20
TOP↑